Lonza is planning a major exansion of its peptides manufacturing
capacities at Visp, Switzerland, in response to what it said was
'the increased demand for peptide active pharmaceutical ingredients
The fine chemicals business unit of Lanxess, which was spun-out
from Germany's Bayer earlier this year and provides custom
manufacturing services to the pharmaceutical and other industries,
has said it plans to expand its geographic...
Schweizerhall is well on the way to completing its acquisition of
Cimex Pharma, and as a result completing the first stage of its
transition to become a specialist supplier to the European generics
industry, reports Phil Taylor.
A second market research report has found evidence that production
capacity in the market for contract manufacturing of
biopharmaceuticals is now in excess, in contrast to the hitherto
prevailing wisdom that the sector has been suffering...
Boehringer Ingelheim Austria has been selected to win a Technology
Leadership award by Frost & Sullivan for its activities in the
contract manufacture of biotherapeutic proteins, and particularly
Canada's Chromos Molecular Systems and AppTec Laboratory Services
have teamed up to provide the biopharmaceutical industry with a
broader range of cell line engineering and contract manufacturing
The pharmaceutical industry is under pressure from downwards price
pressure, a lack of innovation, and the escalating costs of new
product development, and this is having a knock-on effect for
excipients suppliers. Phil Taylor reports.
Construction of the UK National Biomanufacturing Centre, an
ambitious project aimed at helping biotechnology start-ups get
their product ideas into clinical trials, is progressing on
schedule and should be ready to start production...
The market for low-cost generic drugs looks set to be buoyant for
the foreseeable future, both in Europe as a whole and in France,
according to Hubert Olivier, president of the French subsidiary of
the leading German generics group...